Zinc and platelet membrane microviscosity in Alzheimer's disease. The in vivo effect of zinc on platelet membranes and cognition

South African Medical Journal

Volumn 87, Issue 9, 1997, Pages 1116-1119

  Potocnik, Felix C V ^a   Van Rensburg, Susan J ^a   Park, Caron ^b   Taljaard, Joshua J F ^a   Emsley, Robin A ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b Swan Cottage ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; DIET SUPPLEMENTATION; FEMALE; HUMAN; HUMAN CELL; MALE; ORAL DRUG ADMINISTRATION; PSYCHOMETRY; THROMBOCYTE MEMBRANE; VISCOSITY; ZINC BLOOD LEVEL;

AGED; ALZHEIMER DISEASE; BLOOD PLATELETS; COGNITION; FEMALE; HUMANS; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; REFERENCE VALUES; VISCOSITY; ZINC;

EID: 0030662586     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Barinaga M. New Alzheimer's gene found. Science 1995; 268: 1845-1846.
2. Breitner JCS, Murphy EA, Folstein MF, Magruder-Habib K. Twin studies of Alzheimer's disease: an approach to etiology and prevention. Neurobiol Aging 1990; 11: 641-648.
3. Breitner JCS. Onset of Alzheimer's disease: Influence of genes and environmental factors, including anti-inflammatory drugs. In: Heston LL, ed. Progress in Alzheimer's Disease and Similar Conditions. Washington, DC: American Psychiatric Press, 1997: 189-197.
4. Zubenko GS, Cohen BM, Reynolds CF, Boller F, Malinakova I, Keefe N. Platelet membrane fluidity in Alzheimer's disease and major depression. Am J Psychiatry 1987; 144: 860-868.
5. Zubenko GS, Wusylko M, Cohen BM, Boller F, Teply I. Family study of platelet membrane fluidity in Alzheimer's disease. Science 1987; 238: 539-542.
6. Kálmán J, Dey I, Ilona SV, et al. Platelet membrane fluidity and plasma malonaldehyde levels in Alzheimer's demented patients with and without family history of dementia. Biol Psychiatry 1994; 35: 190.
7. Van Rensburg SJ, Carstens ME, Potocnik FCV, Aucamp AK, Taljaard JJF, Koch KR. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes. Neurochem Res 1992; 17: 825-829.
8. Van Rensburg SJ, Daniels WMU, Van Zyl JM, Potocnik FCV, Van der Walt BJ, Taljaard JJF. Lipid peroxidation and platelet membrane fluidity - implications for Alzheimer's disease? NeuroReport 1994; 5: 2221-2224.
9. Szebeni J, Eskelson CD, Chvapil M. The effect of zinc on iron-induced lipid peroxidation in different lipid systems including liposomes and micelles. Physiol Chem Phys Med NMR 1988; 20: 205-211.
10. Jeandel C, Nicolas MB, Dubois F, Nabet-Bellevilte F, Penin F, Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 1989; 35: 275-282.
11. Robertson RN. The Lively Membranes. Cambridge: Cambridge University Press, 1983.
12. Van Rensburg SJ, Potocnik FCV, Carstens ME, Taljaard JJF. Zinc and platelet membrane microviscosity in Alzheimer's disease. The in vitro effect of zinc and aluminium on platelet membranes. Alzheimer's Res 1995; 1: 41-44.
13. Ward NI, Mason JA. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. Journal of Radioanalytical and Nuclear Chemistry 1987; 113: 515-526.
14. Cotman CW, Monaghan DT, Ottersen OP, Storm-Matisen J. Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci 1987; 10: 273-280.
15. 2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature 1987; 328: 640-644.
16. Constantinidis J. The hypothesis of zinc deficiency in the pathogenesis of neurofibrillary tangles. Med Hypoth 1991; 35: 319-323.
17. Bush AI, Pettingell WH, Multhaup G, et al. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 1994; 265: 1464-1467.
18. Mantyh PW, Ghilardi JR, Rogers S, et al. Aluminium, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J Neurochem 1993; 61: 1171-1174.
19. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-III-R). 3rd ed, rev. Washington, DC: APA, 1987.
21. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
22. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 1356-1364.
23. Zee RF. Neuropsychological functioning in Alzheimer's disease. In: Parks RW, Zec RF, Wilson RS, eds. Neuropsychology of Alzheimer's Disease and Other Dementias. Oxford: Oxford University Press, 1993: 3-80.
24. 2+: protection of cells against membrane damage. Biosci Rep 1988; 8: 579-583.
25. Van Rensburg SJ, Carstens ME, Potocnik FCV, Van der Spuy G, Van der Walt BJ, Taljaard JJF. Transferrin C2 and Alzheimer's disease: another piece of the puzzle found? Med Hypoth 1995; 44: 286-272.
26. Driscoll ER, Bettger WJ. Zinc deficiency in the rat alters the lipid composition of the erythrocyte membrane Triton shell. Lipids 1992; 27: 972-977.
27. Van Rhijn AG, Prior CA, Corrigan FM. Dietary supplementation with zinc sulphate, sodium selenite and fatty acids in early dementia of Alzheimer's type. Journal of Nutritional Medicine 1990; 1: 259-266.
28. Martin B. Aluminium speciation in biology. In: Chadwick DJ, Whelan J, eds. Ciba Foundation Symposium 169. Aluminium in Biology and Medicine. Chichester, John Wiley & Sons, 1992: 5-18.
29. Antoniou LD, Sudhakar T, Shalhoub RJ, Smith JC. Reversal of uraemic impotence by zinc. Lancet 1977; 2: 895-898.